GILD: Gilead Sciences, Inc. Stock Live Price Graph
About the company
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $0.82 | $0.82 | 2.59% | - |
What Is GILD? Live GILD Prices and Analysis
Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical needs. Founded in 1987, Gilead has become a leader in antiviral therapies, particularly in the treatment of HIV, hepatitis B, hepatitis C, and influenza. The company's emphasis on research and development has made it a key player in the biotechnology sector, attracting significant interest from investors seeking exposure to the healthcare market.
Investors closely follow GILD due to its strong earnings potential, robust pipeline of drugs, and the critical role it plays in treating various viral infections. With a focus on innovative therapies, Gilead has positioned itself as a vital contributor to global health, making it an important stock for those interested in biotechnology investments.
Market Context
GILD is traded on the NASDAQ exchange, and its stock price is influenced by various factors, including international trading dynamics, currency fluctuations, and overall market volatility. The biotechnology sector is known for its rapid changes and can be significantly impacted by news related to drug approvals, clinical trial results, and regulatory changes. This volatility can lead to swift price movements, making it essential for investors to stay informed about market conditions surrounding Gilead and its competitors.
Why Do GILD Prices Rise or Fall?
The price of GILD stock can be influenced by a multitude of factors that reflect both the company's performance and the broader market sentiment. Understanding these factors can provide valuable insights for investors looking to navigate the stock's volatility.
- Earnings Reports: Quarterly earnings can significantly impact stock prices, especially if results exceed or fall short of analyst expectations.
- Drug Approvals: Successful approval of new drugs by regulatory agencies can boost investor confidence and stock prices.
- Market Competition: The emergence of new competitors in the biotechnology field can affect Gilead's market share and pricing strategies.
- Pipeline Developments: Progress in clinical trials for new treatments can generate excitement among investors and lead to price increases.
- Global Health Trends: Changes in the prevalence of diseases treated by Gilead can influence demand for its products.
- Macroeconomic Factors: Economic conditions, interest rates, and healthcare policy changes can impact investor sentiment and stock performance.
- Dividend Announcements: Any changes to Gilead's dividend policy can affect stock attractiveness to income-focused investors.
- Market Sentiment: Overall investor sentiment towards the biotech sector can drive GILD prices up or down.
In summary, GILD stock prices are influenced by a complex interplay of company-specific developments and broader market trends. Investors should monitor these factors closely to make informed decisions.
Why Is Live GILD Price Tracking Important?
Tracking the live price of GILD is crucial for investors for several reasons:
- Real-Time Decision Making: Real-time price data allows investors to make timely trading decisions.
- Market Trends: Observing price movements helps investors identify trends and potential entry or exit points.
- Performance Monitoring: Investors can assess the performance of their investments and adjust their strategies accordingly.
- Risk Management: Live tracking aids in managing risk by allowing investors to react quickly to market changes.
- Investment Analysis: Detailed price data can enhance fundamental analysis and valuation assessments.
What Should You Consider When Trading / Investing in GILD?
Investing in GILD, like any stock, comes with risks and considerations:
- Volatility: The biotechnology sector is known for its volatility, which can lead to significant price fluctuations.
- Regulatory Risks: Changes in regulations or drug approval processes can impact Gilead's operations and profitability.
- Market Sentiment: Biotech stocks can be heavily influenced by market sentiment, which may not always align with fundamentals.
- Pipeline Risks: The success of Gilead's future growth relies on the success of its drug pipeline, which carries inherent risks.
- Economic Conditions: Broader economic factors can impact healthcare spending and investment in biotech.
What Can You Find on the Investvio GILD Page?
- Live GILD price updates and historical data.
- Interactive charts for technical analysis.
- Latest news and updates related to Gilead Sciences.
- Earnings reports and financial summaries.
- Dividend information and yield calculations.
- Market sentiment analysis and analyst ratings.
In conclusion, Gilead Sciences, Inc. (GILD) presents a compelling opportunity for investors looking to gain exposure to the biotechnology sector. With its strong focus on innovation, robust pipeline, and significant market presence, GILD remains a key stock to watch. For real-time data, insights, and analysis, visit the Investvio GILD page to stay informed and make educated investment decisions.